Assessment of interaction between maternal polycyclic aromatic hydrocarbons exposure and genetic polymorphisms on the risk of congenital heart diseases.. Noninherited risk factors and co
Trang 16 Haney I, Ipp M, Feldman W, McCrindle BW Accuracy of clinical assessment of heart
murmurs by office based (general practice)
paediatricians Arch Dis Child 1999;81:409–
412
7 Li N, Mu Y, Liu Z, et al Assessment of
interaction between maternal polycyclic
aromatic hydrocarbons exposure and genetic polymorphisms on the risk of congenital heart
diseases Sci Rep 2018;8:3075.
8 Jenkins KJ, Correa A, Feinstein JA, et al
Noninherited risk factors and congenital
cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease
in the Young: endorsed by the American
Academy of Pediatrics Circulation.
2007;115:2995–3014
9 Gorini F, Chiappa E, Gargani L, Picano E
Potential effects of environmental chemical contamination in congenital heart disease
Pediatr Cardiol 2014;35:559–568.
10 Liu Z, Yu Y, Li X, et al Maternal lead exposure
and risk of congenital heart defects occurrence
in offspring Reprod Toxicol 2015;51:1–6.
11 Noble J Natural history of Down's syndrome: a
Trang 2screening J Med Screen 1998;5:172–177.
12 Pont SJ, Robbins JM, Bird TM, et al Congenital
malformations among liveborn infants with
trisomies 18 and 13 Am J Med Genet A.
2006;140A:1749–1756
13 Embleton ND, Wyllie JP, Wright MJ, Burn J,
Hunter S Natural history of trisomy 18 Arch Dis Child Fetal Neonatal Ed 1996;75:F38–F41.
14 Wyllie JP, Wright MJ, Burn J, Hunter S Natural
history of trisomy 13 Arch Dis Child.
1994;71:343–345
15 Freeman SB, Taft LF, Dooley KJ, et al
Population-based study of congenital heart
defects in Down syndrome Am J Med Genet.
1998;80:213–217
16 Goldhaber SZ, Rubin IL, Brown W, et al
Valvular heart disease (Aortic regurgitation and mitral valve prolapse) among institutionalized
adults with down's syndrome Am J Cardiol.
1986;57:278–281
17 Cuckle HS, Wald NJ, Thompson SG Estimating
a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum
alpha-fetoprotein level BJOG 1987;94:387–
402
18 Botto LD, May K, Fernhoff PM, et al A
Trang 3population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major
birth defects in the population Pediatrics.
2003;112:101–107
19 Oskarsdottir S Incidence and prevalence of the
22q11 deletion syndrome: a population-based
study in Western Sweden Arch Dis Child.
2004;89:148–151
20 Calcagni G, Digilio MC, Sarkozy A, Dallapiccola
B, Marino B Familial recurrence of congenital heart disease: an overview and review of the
literature Eur J Pediatr 2007;166:111–116.
21 Fahed AC, Gelb BD, Seidman JG, Seidman CE
Genetics of congenital heart disease: the glass
half empty Circ Res 2013;112:707–720.
22 Manning N, Archer N A study to determine the
incidence of structural congenital heart disease
in monochorionic twins Prenat Diagn.
2006;26:1062–1064 [SRC - GoogleScholar]
23 Bryan E, Little J, Burn J Congenital anomalies in
twins Baillieres Clin Obstet Gynaecol.
1987;1:697–721
24 Nakayama D, Masuzaki H, Yoshimura S,
Moriyama S, Ishimaru T Monozygotic twins discordant for single umbilical artery and
congenital heart disease Am J Obstet Gynecol.
1998;179:256–257 [SRC - GoogleScholar]